Similar Blog Posts

MOLCURE Joins Forces with Boehringer Ingelheim to Discover and Develop Innovative Antibody Drugs for Multiple Targets Using Its AI-driven Platform Technology, October 7

MOLCURE Joins Forces with Boehringer Ingelheim to Discover and Develop Innovative Antibody Drugs for Multiple Targets Using Its AI-driven Platform Technology, October 7

Read more
MOLCURE、ベーリンガーインゲルハイムと提携 – AI創薬プラットフォーム技術を活用し、複数の標的に対する革新的な抗体医薬品の創製・開発を目指す-, October 7

MOLCURE、ベーリンガーインゲルハイムと提携 – AI創薬プラットフォーム技術を活用し、複数の標的に対する革新的な抗体医薬品の創製・開発を目指す-, October 7

Read more
MOLCURE at BioJapan 2025, October 8-10

MOLCURE at BioJapan 2025, October 8-10

Read more
BioJapan 2025 出展のお知らせ, October 8-10

BioJapan 2025 出展のお知らせ, October 8-10

Read more